Novain (Oxybuprocaine Hydrochloride)

Oxybuprocaine Hydrochloride, the active ingredient in Novain, is a local anesthetic (ester type) presented as a sterile ophthalmic solution for ocular use. It provides topical anesthesia for diagnostic eye examinations, minor surgical procedures, and relief of corneal irritation in patients of all ages. GNH USA supplies Novain as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Novain is a topical ophthalmic anesthetic used to temporarily block sensory nerve transmission in the eye. - Diagnostic eye examinations: provides rapid, reversible anesthesia for corneal sensitivity testing and slit‑lamp evaluation. - Minor ocular surgeries: facilitates procedures such as cataract extraction, laser photocoagulation, and intraocular lens implantation. - Corneal abrasion or foreign body removal: relieves pain and discomfort during mechanical debridement or extraction.

Novain may cause ocular and systemic reactions, most of which are mild and transient.

Common Side Effects: - Stinging or burning sensation upon instillation. - Transient blurred vision lasting a few minutes. - Conjunctival hyperemia (redness). - Mild tearing or lacrimation. - Temporary increase in intra‑ocular pressure (rare).

Serious or Rare Side Effects: - Allergic contact dermatitis or severe hypersensitivity reaction. - Corneal epithelial toxicity leading to ulceration. - Persistent corneal edema. - Systemic toxicity (e.g., CNS depression) with excessive dosing. - Vision loss if used improperly or in high concentrations.

Novain should be used under professional supervision with attention to patient history and ocular condition. - Allergy assessment: confirm no known hypersensitivity to oxybuprocaine or related ester anesthetics. - Limited duration: avoid prolonged or repeated applications beyond recommended intervals. - Corneal health: do not use on compromised corneal epithelium without specialist advice. - Contact lens wear: advise removal of lenses before administration. - Pediatric use: exercise caution and follow specialist guidance. - Store at room temperature: keep in original container, protect from moisture and direct light.

Novain may interact with other ocular or systemic agents, influencing efficacy or safety.

Major Interactions (Avoid): - Concurrent use of multiple topical ocular anesthetics: risk of cumulative neurotoxicity. - Systemic central nervous system depressants (e.g., barbiturates): potential additive sedation if systemic absorption occurs.

Moderate Interactions (Monitor Closely): - Anticholinergic eye drops (e.g., atropine): may alter pupil response. - Beta‑blocker ophthalmic solutions: possible reduction in intra‑ocular pressure control. - Topical antibiotics: increased risk of local irritation. - Contact lens wear: may enhance drug absorption and irritation.